ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.99
0.00%
US Tech 100
19,750.40
-0.66%
S&P 500
5,849.72
-1.76%
US Dollar vs CAD
1.44134
-0.55%
Bitcoin
83,769.19
-2.69%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. TG Therapeutics Inc (TGTX) Share Price

TG Therapeutics Inc

TG Therapeutics Inc (TGTX)

NASDAQ
34.42
4.33
(14.39%)
Closed March 03 3:00PM
Delayed by 15 minutes
34.02
-0.40
( -1.16% )
Pre Market: 6:24AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
34.02
Bid
34.03
Ask
34.40
Volume
489
0.00 Day's Range 0.00
12.93 52 Week Range 36.84
Market Cap
5.296B
Previous Close
34.42
Open
-
Last Trade
27
@
34.06
Last Trade Time
06:19:44
Financial Volume
-
VWAP
-
Average Volume (3m)
2,306,643
Shares Outstanding
155,665,334
Dividend Yield
-
PE Ratio
422.85
Earnings Per Share (EPS)
0.08
Revenue
233.66M
Net Profit
12.67M

About TG Therapeutics Inc

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, ... TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a unique epitope on the CD20 antigen found on mature B-lymphocytes. It is also developing TGR-1202 (umbralisib), an orally available PI3K delta inhibitor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.tgtherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
TG Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TGTX. The last closing price for TG Therapeutics was US$34.42. Over the last year, TG Therapeutics shares have traded in a share price range of US$ 12.93 to US$ 36.84.

TG Therapeutics currently has 155,665,334 shares outstanding. The market capitalization of TG Therapeutics is US$5.36 billion. TG Therapeutics has a price to earnings ratio (PE ratio) of 422.85.

Ask ADVFN Intelligence (AI)

TG Therapeutics (TGTX) Options Flow Summary

TGTX Options Flow

Overall Flow

Bullish

Net Premium

5M

Calls / Puts

3,133.33%

Buys / Sells

123.68%

OTM / ITM

16.87%

Sweeps Ratio

0.00%

TGTX Latest News

More News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
16 hours ago
TGTX (14.39%)

Form 8-K - Current report
Edgar (US Regulatory)
March 03 2025
TGTX (14.39%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 30 2025
TGTX (14.39%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 30 2025
TGTX (14.39%)

Form 8-K - Current report
Edgar (US Regulatory)
January 14 2025
TGTX (14.39%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.975517.130609926129.044536.428.17417696532.61596153CS
42.03496.3620248178131.985136.428.17222009131.99758884CS
120.93482.8254325196833.085236.427.24230664331.23013006CS
2611.9354.006337709422.0936.8421.11299913028.20181659CS
5216.0989.737869492517.9336.8412.93303763522.89779674CS
15624.67263.850267389.3536.843.48385429415.61220923CS
26020.12144.74820143913.956.743.48302318018.2613063CS

TGTX - Frequently Asked Questions (FAQ)

What is the current TG Therapeutics share price?
The current share price of TG Therapeutics is US$ 34.02
How many TG Therapeutics shares are in issue?
TG Therapeutics has 155,665,334 shares in issue
What is the market cap of TG Therapeutics?
The market capitalisation of TG Therapeutics is USD 5.36B
What is the 1 year trading range for TG Therapeutics share price?
TG Therapeutics has traded in the range of US$ 12.93 to US$ 36.84 during the past year
What is the PE ratio of TG Therapeutics?
The price to earnings ratio of TG Therapeutics is 422.85
What is the cash to sales ratio of TG Therapeutics?
The cash to sales ratio of TG Therapeutics is 22.93
What is the reporting currency for TG Therapeutics?
TG Therapeutics reports financial results in USD
What is the latest annual turnover for TG Therapeutics?
The latest annual turnover of TG Therapeutics is USD 233.66M
What is the latest annual profit for TG Therapeutics?
The latest annual profit of TG Therapeutics is USD 12.67M
What is the registered address of TG Therapeutics?
The registered address for TG Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the TG Therapeutics website address?
The website address for TG Therapeutics is www.tgtherapeutics.com
Which industry sector does TG Therapeutics operate in?
TG Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UOKAMDJM Ltd
US$ 0.2208
(47.20%)
19.41M
PTIXProtagenic Therapeutics Inc
US$ 0.4011
(45.17%)
24.04M
LNKSLinkers Industries Ltd
US$ 0.85
(30.77%)
99
GCLGCL Global Holdings Ltd
US$ 2.59
(28.22%)
601
IKTInhibikase Therapeutics Inc
US$ 2.91
(28.19%)
10
SPGCSacks Parente Golf Inc
US$ 0.114
(-40.00%)
16.06M
SYRESpyre Therapeutics Inc
US$ 11.00
(-38.68%)
4
EVCMEverCommerce Inc
US$ 6.20
(-36.28%)
7
OPCHOption Care Health Inc
US$ 22.01
(-35.19%)
43
MIRMMirum Pharmaceuticals Inc
US$ 32.01
(-30.40%)
78
SUNESUNation Energy Inc
US$ 0.2162
(-9.92%)
49.05M
BTOGBit Origin Ltd
US$ 0.4081
(27.81%)
45.22M
AGMHAGM Group Holdings Inc
US$ 0.1243
(-6.54%)
25.37M
PTIXProtagenic Therapeutics Inc
US$ 0.4037
(46.11%)
24.04M
UOKAMDJM Ltd
US$ 0.22
(46.67%)
19.44M

TGTX Discussion

View Posts
Monksdream Monksdream 2 days ago
TGTX, 10Q due MONDAY 3/3
👍️0
EarningsCentral EarningsCentral 4 months ago
👍️0
Laster Laster 5 months ago
I think we will see a delayed (few days) response to the news.
I am expecting that this will run to $27 by next week and $30 by October.
Definite buyout candidate within the next year. Especially if interest rates are dropping.
JMO.
👍️0
murocman murocman 5 months ago
Could not agree more.

I don’t think they are long for this corporate world as an independent entity.

Murocman
👍️0
Laster Laster 5 months ago
I had to buy some Premarket. This company is a gold mine IMO.
I love stocks near 52 week high. The upward potential here is limitless.
Really excited for the next few months.
I definitely see this company being bought out in the next 52 weeks.
👍️0
Laster Laster 5 months ago
Great news today. Stock at 52-week high.
Just announced $100 million stock buyback.
Compelling story here.
JMO.
👍️0
Monksdream Monksdream 1 year ago
TGTX new 52 week high
👍️0
InspectorBullit InspectorBullit 1 year ago
this should have a very good day tomorrow absent a market meltdown. MS drug par excellence.
👍️0
murocman murocman 1 year ago
I would think we’d be close to the bottom here? Almost at a 52 week low!

GLTA,

Murocman
👍️ 1
kld2 kld2 2 years ago
Cheap at these levels. Should see $20 again before long. Friday should be interesting. If script numbers are good, like last Friday, the share price should get a good boost. Half way through Q3. Dumb drop from $21 to $9.
👍️ 1
Max77 Max77 2 years ago
$TGTX CEO Weiss buys 100k shares at 10.13. Now has 12 million shares
👍️ 1
murocman murocman 2 years ago
Barely above pre-approval prices. Unbelievable.

Murocman
👍️ 1
teifhals teifhals 2 years ago
Anyone catch that Genetech is starting to air commercials since they are losing share?
👍️0
Rayn_Makr Rayn_Makr 2 years ago
Great call this morning. Nice run today and just the beginning with Europe coming on soon.
After Hours Time (ET) After Hours Price After Hours Share Volume
17:27:17 $30.5 5,000
$152,500 in one trade. Short covering???
Fun to think about market cap in 2024 and 2025.
👍️0
Alan Brown Alan Brown 2 years ago
Where did you find such news?
👍️0
Aquahoya Aquahoya 2 years ago
Has anyone checked out $GSTC? Similar biotech company like $TGTX except its much newer and has a patented formulation combinational therapy already FDA approved set and waiting for clinical trial approval in India for Multiple Sclerosis. It is an over-the-counter stock sitting over .01 just waiting for clinical trials approval. The market cap is on $8,000,000. The therapy isn't specific to the type of multiple sclerosis. So, the potential here is huge. The conservative market share that was done by seasoned professionals in the space, that is on their presentation is in the BILLIONs. Read the history here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170524593












👍️0
teifhals teifhals 2 years ago
Whens the buyout..?
👍️ 1
Penny chatter Penny chatter 2 years ago
Lol
👍️0
hawkshaw812 hawkshaw812 2 years ago
Looks like tuseday is shorting day .
👍️0
tw0122 tw0122 2 years ago
They have cash and a better MS drug have the price of Roches. Shorts don’t like
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Not only that but they must be...............

On the wrong side of the trade.

When you get squeezed on them nards, it never feels good.


No mercy....... TAKE THEM OUT !!!!!!!


GO $TGTX
👍️0
tw0122 tw0122 2 years ago
Analysts keep on giving it bad sell ratings.
That must be a good sign. Analysts for the most part just share selling scam artists
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Slowllyy creeping up..... now 11.50 in PreMarket

If it can do exactly what $KALA just did by going over $45, I'm a happy camper


GOOOOOOOOOOOooooooooooooooooooooooooooo hardddddddddddddddddddd



GO $TGTX
👍️0
Ringrock Ringrock 2 years ago
Traded@55.70 Jan 8 ‘21… looks like she’s still got quite a bit togo…
👍️0
shamalamadingdong shamalamadingdong 2 years ago
Dosing of first patients in 30 to 45 days from now/going to the market!!
👍️0
TheFinalCD TheFinalCD 2 years ago
$TGTX No offerings on the horizon per CC

https://twitter.com/cooway/status/1608459299654606848
👍️0
shamalamadingdong shamalamadingdong 2 years ago
Link to 8;30 webcast/conference call.
https://ir.tgtherapeutics.com/events
👍️0
shamalamadingdong shamalamadingdong 2 years ago
Some informative information, pictures of the packaging, disease overview, and more.
https://ml.globenewswire.com/1.0/snippet/1898/eng
👍️0
shamalamadingdong shamalamadingdong 2 years ago
TG Therapeutics Announces FDA Approval Of BRIUMVI; Company To Host Conference Call On Thursday, December 29, 2022 At 8:30 Am ET
👍️0
airman1 airman1 2 years ago
Given a try; on this one in at 8:47 for a morning was jump !!
See if shorts cover before the weekend ??
👍️0
airman1 airman1 2 years ago
Yeah, we may get mm naked! shorts covering tomorrow. Share price may
spike./;)) early GL$$
👍️0
tw0122 tw0122 2 years ago
They have cash and they would let the price go much higher before another offering
👍️0
tw0122 tw0122 2 years ago
$8.73 after hours On a good note company conference 830am and market makers
👍️0
pennyfinder pennyfinder 2 years ago
Probably an offering coming.
👍️0
tw0122 tw0122 2 years ago
Unfortunately lots of illegal naked shorts courtesy of Gary G but see what happens next few days as more shorts cover.
Never a easy game kept a few shares
👍️0
Cheap Stock Investor Cheap Stock Investor 2 years ago
Damn how low is this going? Not headed in right direction at the moment.
👍️0
tw0122 tw0122 2 years ago
MS drug going to make hundreds of millions..

Dec 28 (Reuters) - TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up nearly 9% in afternoon trade.

The approval by the U.S. Food and Drug Administration (FDA) widens the number of such drugs available for treating the disorder to three and may help soften the blow to the company's finances from the withdrawal of its lymphatic cancer drug earlier this year.

TG Therapeutics said it was expecting to launch the drug, branded as Brumvi, in the first quarter of 2023, but did not give details on its pricing.

Jefferies analyst Chris Howerton said ahead of the approval that he was expecting the drug to be priced in the range of $30,000 per patient per year. In comparison, Roche's Ocrevus has a current list price of about $68,000 annually.

Multiple sclerosis is a neurological disease in which the immune system attacks the brain cells causing motor disabilities. It affects about 400,000 people in the United States, according to the National Institutes of Health.

Unlike other MS drugs that target T cells, Brumvi belongs to a class of drugs that tackles B cells' role in driving the inflammation that is central to neurological disease.

The approval, which comes with a warning of infusion reactions from the drug, was based on a late-stage study that showed the drug was effective in reducing the annualized relapse rates in patients. (Reporting by Sriparna Roy, Khushi Mandowara and Raghav Mahobe in Bengaluru; Editing by Anil D'Silva and Shailesh Kuber)
👍️0
SpaceTimeRift777 SpaceTimeRift777 2 years ago
Nice Pump Moon Market
👍️0
tw0122 tw0122 2 years ago
As usual they going to scare folks into
Selling there shares loooks like upper $8s bottom
👍️0
tw0122 tw0122 2 years ago
Still holding about 20% regular short interest and then all the illegal naked Gary G approved ones
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Opens at $11...........


Only the beginning now


GO $TGTX
👍️0
tw0122 tw0122 2 years ago
Can be whatever you want if we see $40s..lol
👍️0
Imarket13 Imarket13 2 years ago
God damn thought you were a woman this whole time
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: I showered.............

Balls, armpits and buttcrack............. good to go.

Took 2mins


GO $TGTX
👍️0
tw0122 tw0122 2 years ago
220pm stand corrected
alfred

@macronewswire
TG THERAPEUTICS (TGTX)TO RESUME TRADING AT 2:20 P.M.
$TGTX
👍️0
Imarket13 Imarket13 2 years ago
I'm hearing within the next hour... everyone wins!!
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Fantastic !!!!!!!!!!!!!


Works for me



GO $TGTX
👍️0
tw0122 tw0122 2 years ago
Halted I believe until 830am
Press release tomorrow. Don’t take my word but pretty sure
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: Whats the big deal about PKPH ???

Did they just get an FDA approval like $TGTX ??

GO $TGTX
👍️0
makinezmoney makinezmoney 2 years ago
$TGTX: No comment


I hope it doesn't open till tomorrow............. then yer filthy for the next 23hrs



GO $TGTX
👍️0

Your Recent History

NASDAQ
TGTX
TG Therapeutics
BIT
UC7BDW
Unicredit Bank
BIT
UC86DK
Unicredit Bank
BIT
UC4AZK
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads